The complete line of Bikini Ready’s women’s weight loss solutions includes Weight Loss Catalyst and Cleanse Cleanse nutritional supplements, as well as Yummy Nutrition Shakes. In 2014, Bikini
Tenofovir alafenamide fumarate (TAF) is a nucleotide reverse transcriptase inhibitor (NRTI) and a new prodrug of tenofovir. This is the company’s second NDA submitted to the FDA for
These tablets are the generic version of US-based pharmaceutical firm Warner Chilcott’s Generess Fe tablets. The US Food and Drug Administration (FDA) has also granted final approval for
The Phase II acne vulgaris trial will be conducted at about ten sites in Australia and New Zealand with Dr Lynda Spelman as the principal investigator. The trial
The drug sponsor, MultiCorp International, has retained Compass Point to manage the product development program. Under the deal, NDA Partners will provide the drug development and regulatory expertise
The agreement allows the alliance to establish a combined oncology sales organization in key markets in advance of the potential launch of avelumab-based treatment regimens in the future.
RTOG Foundation’s partner NRG Oncology will be responsible for conducting the pivotal Phase II/III anal cancer trial of concurrent chemotherapy of mitomycin C/5FU and radiation therapy (CCRT) compared
If approved, this will become the fourth indication for Pradaxa (dabigatran etexilate mesylate). The sNDA is based on the results of two randomized, double-blind Phase III trials, RE-NOVATE
As part of the deal, Sanofi Pasteur will have an option to acquire certain worldwide rights to use VBI’s LPV technology in its vaccines to provide improved stability.
Data from this trial supported the initiation of the ongoing, pivotal Phase II METRIC trial in patients with triple negative breast cancers that over-express glycoprotein NMB (gpNMB). Glembatumumab
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.